RARA CRAFT DATABASE for FDA Medical Devices
510(k)K181718

FDA DEVICE FACTS

BD FlowSmart Set/MiniMed Pro-Set

Becton, Dickinson and Company

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 18, 2018PRODUCT CODEFPA

Indications for use

BD FlowSmart™ Set/MiniMed™ Pro-Set™ is intended for the subcutaneous infusion of medication, including insulin, from an external infusion pump.

There are no changes to the Indications for Use as a result of the device modifications.

Comparison with Predicate Devices: The subject device has the same fundamental scie ntific technology as th e predicated device. The purpose of this submission is to introduce design modifications to the catheter length and introducer needle gauge sizes, labeling and material modifica tions. BD has conducted bench studies confirming that the produc t performance is substantially equivalent to the predicate device. The table below provide s a side by side comparison of the subject device compared to its predicate. Page 7-2

Testing: The subject device has the same technological characteristics as the predicate devices cleared in K160651. BD has verified the modificati ons of the subject device through bench performance and biocompatibility studies.

Bench performance studies included the following test methods: Test Method Acceptance Criteria Results (Pass/Fail) Introducer Needle Integrity during Manual Insertion

Equivalent to predicate device Pass Skin Penetration and Drag Force Equivalent to predicate device Pass Introducer Needle to Needle Hub Strength

Equivalent to predicate device Pass Catheter to Base Attachment Strength Testing in accordance with ISO 10555-1:1995 Pass Tip Radial Strength Equivalent to predicate device Pass

The results of the bench studies successfully demonstrated the subject device has met the requirements.

Biocompatibility studies were conducted per ISO 10993-1 and included:  Comparative chemical characterization  Cytotoxicity evaluation Feature Subject: BD Infusion Set Predicate Device: BD Infusion Set 510(k) Number Pending K160651 Manufacturer BD BD Intended Use

Unchanged

The BD FlowSmart™/MiniMed™ Pro-Set™ infusion set is intended for the subcutaneous infusion of medication, including insulin, from an external infusion pump. System components Unchanged Infusion set + tubing Needle insertion method Unchanged Manual or Automatic via Quickserter (K160860) Angle of Insertion Unchanged Straight 90 degrees Insertion Needle Gauge 29G 30G Catheter Length (mm) 6.6 6.0 Cannula Gauge Unchanged 28G Tubing Connection Type Unchanged Paradigm ® and Luer Lock Tubing Length (in) Unchanged 24, 42 Connection Positions Unchanged Multiple Replacement Frequency Unchanged Disposable, replaced every 72 hours Provided Sterile Unchanged YES Page 7-3

The results of the comparative chemical charac terization demonstrated that there are no new compounds or compounds at higher levels in th e subject device compared to the predicate device. An insulin compatibility study was performed to demonstrate insulin compatibility.

The testing demonstrates the BD FlowSmart™ Set/MiniMed™ Pro-Set™ device meet requirements for its intended use and is substantially equivalent to its predicate device.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026